Efficacy and outcomes of CYP3A5 genotype-based tacrolimus dosing compared to conventional body weight-based dosing in living donor kidney transplant recipients-Reference-Cited by-同舟云学术

Efficacy and outcomes of CYP3A5 genotype-based tacrolimus dosing compared to conventional body weight-based dosing in living donor kidney transplant recipients

Published:2022 Issue:3 Volume:32 Page:240
ISSN:0971-4065
Container-title:Indian Journal of Nephrology
language:en
Short-container-title:Indian J Nephrol

Author:

Edwin Fernando M,Yashwanth Raj T,Srinivasa prasad ND,Sujit S,Thirumal Valavan K,Harshavardhan TS,Ramanathan Arvind

Publisher

Medknow

Subject

Nephrology

Reference18 articles.

1. OPTN/SRTR 2012 annual data report: Kidney;Matas;Am J Transplant,2014

2. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet,2004

3. Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference;Wallemacq;Ther Drug Monit,2009

4. KDIGO clinical practice guideline for the care of kidney transplant recipients;Kidney;Am J Transplant,2009

5. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients;Haufroid;Pharmacogenetics,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15

2. Influence of Cyp3A4, Cyp3A5 and ABCB1 Polymorphisms on Tacrolimus Concentrations and Rejection Risk in Indian Kidney Transplant Recipients;Indian Journal of Transplantation;2024-01